St. Louis School of Medicine: What to Know About the New Alzheimer's Drug Leqembi
August 17, 2023
August 17, 2023
ST. LOUIS, Missouri, Aug. 17 -- The Washington University St. Louis School of Medicine issued the following Q&A on Aug. 16, 2023, with Barbara Joy Snider, professor of neurology at Washington University:
* * *
The Food and Drug Administration (FDA) recently gave full approval to Leqembi (lecanemab) for patients in the early stages of Alzheimer's disease. Physicians and researchers at Washington University School of Medicine's Charles F. and Joanne Knight A . . .
* * *
The Food and Drug Administration (FDA) recently gave full approval to Leqembi (lecanemab) for patients in the early stages of Alzheimer's disease. Physicians and researchers at Washington University School of Medicine's Charles F. and Joanne Knight A . . .